In a year dominated by COVID-19, the countdown for 2021 has been dominated by stories about the gut, vitamins, minerals and anything else linked to supporting immune health and warding off the virus’ effects.
Consumer trends, technological advancements and business strategies are causing the pharma and nutra markets to merge and this opens opportunities for the players in both industries to cater to consumers looking for the ultimate wellness solutions.
A meta-analysis of 13 clinical trials on more than 500,000 COVID-19 patients revealed no significant association between vitamin D supplementation and improved clinical outcomes based on current evidence.
The fallout from the pandemic has pulled probiotics sharply into focus as firms attempt to navigate ever shifting health positioning and price points to satisfy a surge in gut and immune health interest.
Personalised Nutrition (PN) offers opportunities both for performance and active sports nutrition, according to FMCG Gurus’ Head of Research & Insight, Mike Hughes but affordability remains a sticking issue.
Nutraceutical ingredient suppliers and manufacturers are continuing to ramp-up their inventory to keep their supply chain stable amid ongoing uncertainties brought by the COVID-19 pandemic, including port closures and delayed vessels.